CytomX Therapeutics Ownership 2024 | Who Owns CytomX Therapeutics Now?
Institutional Ownership
10.26%
Insider Ownership
1.00%
Retail Ownership
88.74%
Institutional Holders
24.00
CytomX Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 9.50% | 0.97% | 7,791,936 | 1,341,936 | 20.81% | 9,506,162 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 7.68% | 0.00% | 6,301,983 | 6,301,983 | 100.00% | 7,719,929 | Jun 30, 2024 |
| BVF INC/IL | 6.37% | 0.18% | 5,228,461 | -1,367,340 | -20.73% | 6,378,722 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.96% | 0.00% | 4,892,302 | 34,928 | 0.72% | 5,968,608 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.66% | 0.01% | 3,000,000 | 1,000,000 | 50.00% | 3,660,000 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 3.33% | 0.01% | 2,728,569 | 37,739 | 1.40% | 3,324,000 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 2.25% | 0.00% | 1,845,403 | 1,173,775 | 174.77% | 2,251,392 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 1.86% | 0.02% | 1,526,387 | 762,200 | 99.74% | 1,862,192 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.84% | 0.01% | 1,507,717 | 977,782 | 184.51% | 1,839,415 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 1.68% | 0.01% | 1,375,290 | 100,783 | 7.91% | 1,677,853 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 1.51% | 0.00% | 1,238,499 | 833,825 | 206.05% | 1,510,969 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 1.46% | 0.02% | 1,200,002 | 1,200,002 | 100.00% | 1,464,002 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.44% | 0.00% | 1,183,022 | -49,778 | -4.04% | 1,443,287 | Jun 30, 2024 |
| CONGRESS PARK CAPITAL LLC | 1.41% | 0.57% | 1,153,220 | 919,420 | 393.25% | 1,406,929 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 1.40% | 1.77% | 1,151,518 | 472,115 | 69.49% | 1,404,852 | Jun 30, 2024 |
| BLACKROCK INC. | 1.39% | - | 1,139,029 | 7,821 | 0.69% | 1,389,616 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.94% | 0.00% | 769,499 | 16,101 | 2.14% | 939,006 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.81% | 0.00% | 661,947 | 408,174 | 160.84% | 807,575 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.70% | 0.13% | 572,170 | 417,170 | 269.14% | 698,047 | Jun 30, 2024 |
| SEI INVESTMENTS CO | 0.47% | 0.00% | 382,723 | 382,723 | 100.00% | 466,922,000 | Jun 30, 2024 |
CytomX Therapeutics's largest institutional shareholder is TANG CAPITAL MANAGEMENT LLC, holding 9.50% of the company's total share outstanding, currently valued at $9.51M. The top 10 institutional shareholders own together 44.13% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SUPERSTRING CAPITAL MANAGEMENT LP | 1.40% | 1.77% | 1,151,518 | 472,115 | 69.49% | 1,404,852 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 9.50% | 0.97% | 7,791,936 | 1,341,936 | 20.81% | 9,506,162 | Jun 30, 2024 |
| CONGRESS PARK CAPITAL LLC | 1.41% | 0.57% | 1,153,220 | 919,420 | 393.25% | 1,406,929 | Jun 30, 2024 |
| BVF INC/IL | 6.37% | 0.18% | 5,228,461 | -1,367,340 | -20.73% | 6,378,722 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.70% | 0.13% | 572,170 | 417,170 | 269.14% | 698,047 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.37% | 0.11% | 300,000 | -300,000 | -50.00% | 366,000 | Jun 30, 2024 |
| FORMIDABLE ASSET MANAGEMENT, LLC | 0.31% | 0.05% | 258,001 | -30,100 | -10.45% | 314,761 | Jun 30, 2024 |
| FOREFRONT ANALYTICS, LLC | 0.08% | 0.04% | 64,065 | 43,176 | 206.69% | 78,159 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 1.46% | 0.02% | 1,200,002 | 1,200,002 | 100.00% | 1,464,002 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 1.86% | 0.02% | 1,526,387 | 762,200 | 99.74% | 1,862,192 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.28% | 0.02% | 229,093 | 80,526 | 54.20% | 279,000 | Jun 30, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | 0.10% | 0.02% | 80,591 | -761 | -0.94% | 98,321 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 1.68% | 0.01% | 1,375,290 | 100,783 | 7.91% | 1,677,853 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.45% | 0.01% | 369,124 | -74,100 | -16.72% | 450,331 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 3.33% | 0.01% | 2,728,569 | 37,739 | 1.40% | 3,324,000 | Jun 30, 2024 |
| NIERENBERG INVESTMENT MANAGEMENT COMPANY, INC. | 0.02% | 0.01% | 12,555 | 12,555 | 100.00% | 15,317 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.84% | 0.01% | 1,507,717 | 977,782 | 184.51% | 1,839,415 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.66% | 0.01% | 3,000,000 | 1,000,000 | 50.00% | 3,660,000 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.07% | 0.01% | 60,586 | 48,033 | 382.64% | 73,915 | Jun 30, 2024 |
| WESTHILL FINANCIAL ADVISORS, INC. | 0.02% | 0.01% | 17,082 | - | - | 20,840 | Jun 30, 2024 |
The largest CytomX Therapeutics shareholder by % of total assets is SUPERSTRING CAPITAL MANAGEMENT LP. The company owns 1.15M shares of CytomX Therapeutics (CTMX), representing 1.77% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 7.68% | 0.00% | 6,301,983 | 6,301,983 | 100.00% | 7,719,929 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 9.50% | 0.97% | 7,791,936 | 1,341,936 | 20.81% | 9,506,162 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 1.46% | 0.02% | 1,200,002 | 1,200,002 | 100.00% | 1,464,002 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 2.25% | 0.00% | 1,845,403 | 1,173,775 | 174.77% | 2,251,392 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.66% | 0.01% | 3,000,000 | 1,000,000 | 50.00% | 3,660,000 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.84% | 0.01% | 1,507,717 | 977,782 | 184.51% | 1,839,415 | Jun 30, 2024 |
| CONGRESS PARK CAPITAL LLC | 1.41% | 0.57% | 1,153,220 | 919,420 | 393.25% | 1,406,929 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 1.51% | 0.00% | 1,238,499 | 833,825 | 206.05% | 1,510,969 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 1.86% | 0.02% | 1,526,387 | 762,200 | 99.74% | 1,862,192 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 1.40% | 1.77% | 1,151,518 | 472,115 | 69.49% | 1,404,852 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.70% | 0.13% | 572,170 | 417,170 | 269.14% | 698,047 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.81% | 0.00% | 661,947 | 408,174 | 160.84% | 807,575 | Jun 30, 2024 |
| SEI INVESTMENTS CO | 0.47% | 0.00% | 382,723 | 382,723 | 100.00% | 466,922,000 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 0.26% | 0.00% | 210,027 | 210,027 | 100.00% | 256,221 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 1.68% | 0.01% | 1,375,290 | 100,783 | 7.91% | 1,677,853 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.28% | 0.02% | 229,093 | 80,526 | 54.20% | 279,000 | Jun 30, 2024 |
| FMR LLC | 0.30% | - | 242,358 | 59,281 | 32.38% | 295,677 | Jun 30, 2024 |
| UBS GROUP AG | 0.09% | - | 70,368 | 49,875 | 243.38% | 85,849 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.07% | 0.01% | 60,586 | 48,033 | 382.64% | 73,915 | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | 0.06% | 0.00% | 47,100 | 47,100 | 100.00% | 57,462 | Jun 30, 2024 |
As of Jun 30 2024, CytomX Therapeutics's largest institutional buyer is JANUS HENDERSON GROUP PLC. The company purchased 6.30M stocks of CTMX, valued at $7.72M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | - | - | - | -3,544,578 | -100.00% | - | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | - | - | - | -1,598,590 | -100.00% | - | Jun 30, 2024 |
| BVF INC/IL | 6.37% | 0.18% | 5,228,461 | -1,367,340 | -20.73% | 6,378,722 | Jun 30, 2024 |
| BRONTE CAPITAL MANAGEMENT PTY LTD. | - | - | - | -906,157 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.23% | - | 188,486 | -667,498 | -77.98% | 229,953 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.37% | 0.11% | 300,000 | -300,000 | -50.00% | 366,000 | Jun 30, 2024 |
| CLEARLINE CAPITAL LP | - | - | - | -196,583 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -191,060 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.13% | - | 109,302 | -184,592 | -62.81% | 133,348 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | - | - | - | -107,700 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -87,226 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -85,638 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.07% | 0.00% | 54,608 | -78,591 | -59.00% | 66,622 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.45% | 0.01% | 369,124 | -74,100 | -16.72% | 450,331 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.01% | - | 5,744 | -72,070 | -92.62% | 7,007 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.04% | - | 36,315 | -56,000 | -60.66% | 44,304 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -55,595 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -52,289 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.31% | 0.00% | 254,220 | -50,114 | -16.47% | 310,148 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.44% | 0.00% | 1,183,022 | -49,778 | -4.04% | 1,443,287 | Jun 30, 2024 |
As of Jun 30 2024, CytomX Therapeutics's biggest institutional seller is ORBIMED ADVISORS LLC. The company sold -3.54M shares of CTMX, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 7.68% | 0.00% | 6,301,983 | 6,301,983 | 100.00% | 7,719,929 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 1.46% | 0.02% | 1,200,002 | 1,200,002 | 100.00% | 1,464,002 | Jun 30, 2024 |
| SEI INVESTMENTS CO | 0.47% | 0.00% | 382,723 | 382,723 | 100.00% | 466,922,000 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 0.26% | 0.00% | 210,027 | 210,027 | 100.00% | 256,221 | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | 0.06% | 0.00% | 47,100 | 47,100 | 100.00% | 57,462 | Jun 30, 2024 |
| INVESCO LTD. | 0.03% | - | 23,094 | 23,094 | 100.00% | 28,175 | Jun 30, 2024 |
| NIERENBERG INVESTMENT MANAGEMENT COMPANY, INC. | 0.02% | 0.01% | 12,555 | 12,555 | 100.00% | 15,317 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.01% | 0.00% | 8,924 | 8,924 | 100.00% | 10,887 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 900 | 900 | 100.00% | 1,098 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | - | - | 2 | 2 | 100.00% | 2 | Jun 30, 2024 |
CytomX Therapeutics's largest new institutional shareholder by number of shares is JANUS HENDERSON GROUP PLC, purchased 6.30M shares, valued at $7.72M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | - | - | - | -3,544,578 | -100.00% | - | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | - | - | - | -1,598,590 | -100.00% | - | Jun 30, 2024 |
| BRONTE CAPITAL MANAGEMENT PTY LTD. | - | - | - | -906,157 | -100.00% | - | Jun 30, 2024 |
| CLEARLINE CAPITAL LP | - | - | - | -196,583 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -191,060 | -100.00% | - | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | - | - | - | -107,700 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | - | - | - | -87,226 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -85,638 | -100.00% | - | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | - | - | - | -55,595 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -52,289 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -47,000 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -43,865 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -38,578 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -35,400 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -31,921 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -26,114 | -100.00% | - | Jun 30, 2024 |
| CTC ALTERNATIVE STRATEGIES, LTD. | - | - | - | -18,900 | -100.00% | - | Jun 30, 2024 |
| MACKENZIE FINANCIAL CORP | - | - | - | -18,138 | -100.00% | - | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | - | - | - | -18,056 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -16,831 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -11,049 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -10,811 | -100.00% | - | Jun 30, 2024 |
| VONTOBEL HOLDING LTD. | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -1,134 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -524 | -100.00% | - | Jun 30, 2024 |
| OLD POINT TRUST & FINANCIAL SERVICES N A | - | - | - | -250 | -100.00% | - | Jun 30, 2024 |
CytomX Therapeutics's largest sold out institutional shareholder by shares sold is ORBIMED ADVISORS LLC, sold -3.54M shares, valued at -, as of undefined.
CytomX Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| CORNERCAP GROUP OF FUNDS /VA/ | 1.10% | 79,697 | 42,854 | 116.32% | Sep 30, 2022 |
| HARTFORD HLS SERIES FUND II INC | 0.99% | 242,009 | - | - | Dec 31, 2023 |
| BRIDGEWAY FUNDS INC | 0.19% | 443,224 | 8,700 | 2.00% | Mar 28, 2024 |
| Federated Hermes MDT Series | 0.15% | 375,757 | - | - | Jan 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.15% | 76,520 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.10% | 376,380 | - | - | Mar 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.09% | 298,669 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.09% | 46,219 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.07% | 1,528 | - | - | Dec 31, 2023 |
| VANGUARD EXPLORER FUND | 0.07% | 820,461 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL FUNDS | 0.06% | 44,909 | - | - | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.06% | 1,760,500 | - | - | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.05% | 257,766 | - | - | Mar 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.02% | 555,119 | -555,119 | -50.00% | Mar 31, 2024 |
| AMG Funds I | 0.02% | 44,022 | - | - | Jan 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.02% | 223,159 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.02% | 43,642 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 111,108 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.02% | 25,634 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 10,055 | - | - | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.02% | 106,678 | - | - | Aug 31, 2023 |
| PFM Multi-Manager Series Trust | 0.01% | 9,891 | - | - | Dec 31, 2023 |
| Bernstein Fund Inc | 0.01% | 87,837 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.01% | 14,198 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 3,132,025 | -943,321 | -23.15% | Mar 31, 2024 |
| JNL VARIABLE FUND LLC | 0.01% | 37,198 | - | - | Mar 31, 2020 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 20,688 | - | - | Feb 29, 2024 |
| GABELLI EQUITY TRUST INC | 0.01% | 8,000 | - | - | Dec 29, 2023 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 409,885 | - | - | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.01% | 105,458 | -1,220 | -1.14% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,148 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.01% | 62,022 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.01% | 63,306 | - | - | Feb 29, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 78,372 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 235,814 | -45,569 | -16.19% | Mar 31, 2024 |
| SSGA FUNDS | 0.00% | 1,955 | - | - | Feb 29, 2024 |
| Legg Mason ETF Investment Trust | 0.00% | 6,017 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 612,134 | 31,649 | 5.45% | Feb 29, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 10,917 | - | - | Mar 31, 2024 |
| Destra Investment Trust | 0.00% | 3,103 | - | - | Mar 31, 2024 |
| Managed Portfolio Series | 0.00% | 41,458 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 5,010 | - | - | Mar 31, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 16,705 | - | - | Feb 29, 2024 |
| GPS Funds I | 0.00% | 8,003 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 44,926 | -3,242 | -6.73% | Mar 31, 2024 |
| MML SERIES INVESTMENT FUND | 0.00% | 11,343 | - | - | Dec 31, 2023 |
| Direxion Shares ETF Trust | 0.00% | 179,792 | - | - | Jan 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 114,504 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 140,441 | - | - | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 19,385 | - | - | Mar 31, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 40,358 | - | - | Mar 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 22,800 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 25,786 | - | - | Mar 31, 2024 |
| AMG FUNDS III | 0.00% | 3,788 | - | - | Mar 28, 2024 |
| SunAmerica Specialty Series | 0.00% | 372 | - | - | Apr 30, 2021 |
| VANGUARD WORLD FUND | 0.00% | 166,339 | - | - | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 7,545 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 24,817 | - | - | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 51,570 | - | - | Jan 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 294,819 | - | - | Feb 29, 2024 |
| Virtus Investment Trust | 0.00% | 16,289 | - | - | Mar 28, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,232 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,181 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 18,277 | - | - | Jan 31, 2024 |
| OLD WESTBURY FUNDS INC | 0.00% | 49,203 | - | - | Jan 31, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 3,457 | - | - | Mar 28, 2024 |
| NORTHERN FUNDS | 0.00% | 35,829 | - | - | Mar 28, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 905 | - | - | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 13,675 | - | - | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 16,979 | - | - | Jan 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 15,604 | - | - | Jan 31, 2024 |
| JPMorgan Trust I | 0.00% | 244,050 | - | - | Jan 31, 2024 |
| GLENMEDE FUND INC | 0.00% | 1,458 | - | - | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 10,545 | - | - | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 617 | - | - | Dec 31, 2023 |
| Goldman Sachs ETF Trust | 0.00% | 11,777 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 1,387 | - | - | Mar 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 12,555 | - | - | Mar 28, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 451,554 | - | - | Mar 31, 2024 |
| LoCorr Investment Trust | 0.00% | 2,699 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 214,086 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 2,252 | - | - | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 342 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 24,040 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 2,400 | - | - | Mar 28, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 26,556 | -19,700 | -42.59% | Jan 31, 2024 |
| GMO TRUST | 0.00% | 113,599 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 22,364 | - | - | Jan 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 386 | - | - | Feb 29, 2024 |
| THRIVENT MUTUAL FUNDS | 0.00% | 5,862 | - | - | Mar 28, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 8,192 | - | - | Jan 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 257,500 | - | - | Mar 31, 2024 |
| PGIM ETF TRUST | 0.00% | 3,612 | - | - | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 63 | - | - | Dec 31, 2023 |
| TIAA-CREF FUNDS | 0.00% | 160,896 | - | - | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 4,473 | - | - | Mar 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 2,539 | - | - | Dec 31, 2023 |
| ADVANCED SERIES TRUST | 0.00% | 148,650 | - | - | Mar 28, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 12,870 | -1,549 | -10.74% | Jan 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 4,500 | 700 | 18.42% | Mar 31, 2024 |
CytomX Therapeutics's largest mutual fund holder by % of total assets is "CORNERCAP GROUP OF FUNDS /VA/", owning 79.70K shares, compromising 1.10% of its total assets.
CytomX Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 24 | -73.63% |
| 31 Mar, 24 | 91 | 33.82% |
| 31 Dec, 23 | 68 | 7.94% |
| 30 Sep, 23 | 63 | -7.35% |
| 30 Jun, 23 | 68 | -11.69% |
| 31 Mar, 23 | 77 | -7.23% |
| 31 Dec, 22 | 83 | 3.75% |
| 30 Sep, 22 | 80 | -13.04% |
| 30 Jun, 22 | 92 | -22.03% |
| 31 Mar, 22 | 118 | 3.51% |
| 31 Dec, 21 | 114 | -0.87% |
| 30 Sep, 21 | 115 | -6.50% |
| 30 Jun, 21 | 123 | -6.82% |
| 31 Mar, 21 | 132 | 4.76% |
| 31 Dec, 20 | 126 | -3.82% |
| 30 Sep, 20 | 131 | -2.96% |
| 30 Jun, 20 | 135 | 16.38% |
| 31 Mar, 20 | 116 | -3.33% |
| 31 Dec, 19 | 120 | 5.26% |
| 30 Sep, 19 | 114 | 4.59% |
| 30 Jun, 19 | 109 | -4.39% |
| 31 Mar, 19 | 114 | -0.87% |
| 31 Dec, 18 | 115 | -8.00% |
| 30 Sep, 18 | 125 | -14.97% |
| 30 Jun, 18 | 147 | 3.52% |
| 31 Mar, 18 | 142 | 18.33% |
| 31 Dec, 17 | 120 | 23.71% |
| 30 Sep, 17 | 97 | 7.78% |
| 30 Jun, 17 | 90 | 3.45% |
| 31 Mar, 17 | 87 | 27.94% |
| 31 Dec, 16 | 68 | 9.68% |
| 30 Sep, 16 | 62 | 3.33% |
| 30 Jun, 16 | 60 | 22.45% |
| 31 Mar, 16 | 49 | 2.08% |
| 31 Dec, 15 | 48 | - |
As of 30 Jun 24, 24 institutions are holding CytomX Therapeutics's shares, representing a decrease of -73.63% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 8,413,698 | -81.01% |
| 31 Mar, 24 | 44,300,462 | 36.07% |
| 31 Dec, 23 | 32,557,314 | 0.67% |
| 30 Sep, 23 | 32,341,071 | -5.07% |
| 30 Jun, 23 | 34,068,157 | -4.15% |
| 31 Mar, 23 | 35,541,812 | -1.61% |
| 31 Dec, 22 | 36,124,460 | -0.44% |
| 30 Sep, 22 | 36,284,253 | -20.40% |
| 30 Jun, 22 | 45,582,258 | -15.06% |
| 31 Mar, 22 | 53,663,164 | -1.69% |
| 31 Dec, 21 | 54,587,431 | 1.12% |
| 30 Sep, 21 | 53,985,309 | -4.71% |
| 30 Jun, 21 | 56,651,462 | 3.72% |
| 31 Mar, 21 | 54,621,973 | 43.76% |
| 31 Dec, 20 | 37,995,676 | 3.14% |
| 30 Sep, 20 | 36,839,372 | -2.44% |
| 30 Jun, 20 | 37,759,346 | 4.62% |
| 31 Mar, 20 | 36,090,579 | 0.25% |
| 31 Dec, 19 | 36,002,168 | 0.46% |
| 30 Sep, 19 | 35,838,126 | 0.54% |
| 30 Jun, 19 | 35,647,408 | -3.86% |
| 31 Mar, 19 | 37,077,308 | -1.94% |
| 31 Dec, 18 | 37,812,212 | 0.04% |
| 30 Sep, 18 | 37,795,442 | 16.65% |
| 30 Jun, 18 | 32,400,939 | 8.92% |
| 31 Mar, 18 | 29,746,208 | -1.33% |
| 31 Dec, 17 | 30,146,896 | 24.36% |
| 30 Sep, 17 | 24,242,513 | 9.67% |
| 30 Jun, 17 | 22,105,789 | 15.11% |
| 31 Mar, 17 | 19,204,334 | 13.92% |
| 31 Dec, 16 | 16,857,722 | -14.54% |
| 30 Sep, 16 | 19,725,253 | 4.67% |
| 30 Jun, 16 | 18,845,786 | 6.69% |
| 31 Mar, 16 | 17,663,927 | 1.79% |
| 31 Dec, 15 | 17,354,128 | - |
CytomX Therapeutics (CTMX) has 8.41M shares outstanding as of 30 Jun 24, down -81.01% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 10.26% | 0.28% |
| 31 Mar, 24 | 60.02% | 3.69% |
| 31 Dec, 23 | 40.33% | 1.71% |
| 30 Sep, 23 | 48.61% | 1.84% |
| 30 Jun, 23 | 51.42% | 1.79% |
| 31 Mar, 23 | 53.65% | 1.78% |
| 31 Dec, 22 | 54.95% | 1.81% |
| 30 Sep, 22 | 55.05% | 1.14% |
| 30 Jun, 22 | 69.55% | 1.03% |
| 31 Mar, 22 | 82.06% | 1.17% |
| 31 Dec, 21 | 83.71% | 1.22% |
| 30 Sep, 21 | 82.79% | 1.09% |
| 30 Jun, 21 | 87.08% | 1.08% |
| 31 Mar, 21 | 89.59% | 1.32% |
| 31 Dec, 20 | 82.34% | 1.29% |
| 30 Sep, 20 | 79.75% | 1.19% |
| 30 Jun, 20 | 81.98% | 1.32% |
| 31 Mar, 20 | 78.93% | 1.27% |
| 31 Dec, 19 | 78.74% | 1.26% |
| 30 Sep, 19 | 78.91% | 1.28% |
| 30 Jun, 19 | 78.62% | 1.16% |
| 31 Mar, 19 | 82.17% | 1.17% |
| 31 Dec, 18 | 83.80% | 1.13% |
| 30 Sep, 18 | 86.06% | 1.24% |
| 30 Jun, 18 | 83.16% | 1.40% |
| 31 Mar, 18 | 76.97% | 1.17% |
| 31 Dec, 17 | 81.11% | 1.88% |
| 30 Sep, 17 | 65.61% | 1.82% |
| 30 Jun, 17 | 60.10% | 2.18% |
| 31 Mar, 17 | 52.56% | 2.43% |
| 31 Dec, 16 | 46.52% | 1.58% |
| 30 Sep, 16 | 54.30% | 1.99% |
| 30 Jun, 16 | 52.19% | 2.18% |
| 31 Mar, 16 | 48.98% | 2.12% |
| 31 Dec, 15 | 48.12% | - |
As of 30 Jun 24, CytomX Therapeutics is held by 10.26% institutional shareholders, representing a 0.28% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 10 | -78.26% |
| 31 Mar, 24 | 46 | 91.67% |
| 31 Dec, 23 | 24 | 71.43% |
| 30 Sep, 23 | 14 | -44.00% |
| 30 Jun, 23 | 25 | 25.00% |
| 31 Mar, 23 | 20 | -42.86% |
| 31 Dec, 22 | 35 | 6.06% |
| 30 Sep, 22 | 33 | -26.67% |
| 30 Jun, 22 | 45 | -18.18% |
| 31 Mar, 22 | 55 | 14.58% |
| 31 Dec, 21 | 48 | 4.35% |
| 30 Sep, 21 | 46 | -33.33% |
| 30 Jun, 21 | 69 | -6.76% |
| 31 Mar, 21 | 74 | 37.04% |
| 31 Dec, 20 | 54 | -8.47% |
| 30 Sep, 20 | 59 | -26.25% |
| 30 Jun, 20 | 80 | 53.85% |
| 31 Mar, 20 | 52 | -24.64% |
| 31 Dec, 19 | 69 | 16.95% |
| 30 Sep, 19 | 59 | -6.35% |
| 30 Jun, 19 | 63 | 3.28% |
| 31 Mar, 19 | 61 | 19.61% |
| 31 Dec, 18 | 51 | -28.17% |
| 30 Sep, 18 | 71 | -20.22% |
| 30 Jun, 18 | 89 | 12.66% |
| 31 Mar, 18 | 79 | -2.47% |
| 31 Dec, 17 | 81 | 32.79% |
| 30 Sep, 17 | 61 | - |
| 30 Jun, 17 | 61 | 7.02% |
| 31 Mar, 17 | 57 | 50.00% |
| 31 Dec, 16 | 38 | 31.03% |
| 30 Sep, 16 | 29 | -36.96% |
| 30 Jun, 16 | 46 | 76.92% |
| 31 Mar, 16 | 26 | -45.83% |
| 31 Dec, 15 | 48 | - |
10 institutional shareholders have increased their position in CTMX stock as of 30 Jun 24 compared to 46 in the previous quarter (a -78.26% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 9 | -64.00% |
| 31 Mar, 24 | 25 | 25.00% |
| 31 Dec, 23 | 20 | -20.00% |
| 30 Sep, 23 | 25 | 31.58% |
| 30 Jun, 23 | 19 | -47.22% |
| 31 Mar, 23 | 36 | 80.00% |
| 31 Dec, 22 | 20 | -13.04% |
| 30 Sep, 22 | 23 | -11.54% |
| 30 Jun, 22 | 26 | -36.59% |
| 31 Mar, 22 | 41 | -6.82% |
| 31 Dec, 21 | 44 | -2.22% |
| 30 Sep, 21 | 45 | 32.35% |
| 30 Jun, 21 | 34 | -2.86% |
| 31 Mar, 21 | 35 | -30.00% |
| 31 Dec, 20 | 50 | 4.17% |
| 30 Sep, 20 | 48 | 29.73% |
| 30 Jun, 20 | 37 | -11.90% |
| 31 Mar, 20 | 42 | 23.53% |
| 31 Dec, 19 | 34 | 3.03% |
| 30 Sep, 19 | 33 | 13.79% |
| 30 Jun, 19 | 29 | -14.71% |
| 31 Mar, 19 | 34 | -20.93% |
| 31 Dec, 18 | 43 | 38.71% |
| 30 Sep, 18 | 31 | -27.91% |
| 30 Jun, 18 | 43 | -2.27% |
| 31 Mar, 18 | 44 | 83.33% |
| 31 Dec, 17 | 24 | 50.00% |
| 30 Sep, 17 | 16 | 14.29% |
| 30 Jun, 17 | 14 | -30.00% |
| 31 Mar, 17 | 20 | 53.85% |
| 31 Dec, 16 | 13 | - |
| 30 Sep, 16 | 13 | 116.67% |
| 30 Jun, 16 | 6 | -45.45% |
| 31 Mar, 16 | 11 | - |
| 31 Dec, 15 | - | - |
9 institutional shareholders have reduced their position in CTMX stock as of 30 Jun 24 compared to 25 in the previous quarter (a -64.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 24 | -73.63% | 8,413,698 | -81.01% | 10.26% | 0.28% | 10 | -78.26% | 9 | -64.00% |
| 31 Mar, 24 | 91 | 33.82% | 44,300,462 | 36.07% | 60.02% | 3.69% | 46 | 91.67% | 25 | 25.00% |
| 31 Dec, 23 | 68 | 7.94% | 32,557,314 | 0.67% | 40.33% | 1.71% | 24 | 71.43% | 20 | -20.00% |
| 30 Sep, 23 | 63 | -7.35% | 32,341,071 | -5.07% | 48.61% | 1.84% | 14 | -44.00% | 25 | 31.58% |
| 30 Jun, 23 | 68 | -11.69% | 34,068,157 | -4.15% | 51.42% | 1.79% | 25 | 25.00% | 19 | -47.22% |
| 31 Mar, 23 | 77 | -7.23% | 35,541,812 | -1.61% | 53.65% | 1.78% | 20 | -42.86% | 36 | 80.00% |
| 31 Dec, 22 | 83 | 3.75% | 36,124,460 | -0.44% | 54.95% | 1.81% | 35 | 6.06% | 20 | -13.04% |
| 30 Sep, 22 | 80 | -13.04% | 36,284,253 | -20.40% | 55.05% | 1.14% | 33 | -26.67% | 23 | -11.54% |
| 30 Jun, 22 | 92 | -22.03% | 45,582,258 | -15.06% | 69.55% | 1.03% | 45 | -18.18% | 26 | -36.59% |
| 31 Mar, 22 | 118 | 3.51% | 53,663,164 | -1.69% | 82.06% | 1.17% | 55 | 14.58% | 41 | -6.82% |
| 31 Dec, 21 | 114 | -0.87% | 54,587,431 | 1.12% | 83.71% | 1.22% | 48 | 4.35% | 44 | -2.22% |
| 30 Sep, 21 | 115 | -6.50% | 53,985,309 | -4.71% | 82.79% | 1.09% | 46 | -33.33% | 45 | 32.35% |
| 30 Jun, 21 | 123 | -6.82% | 56,651,462 | 3.72% | 87.08% | 1.08% | 69 | -6.76% | 34 | -2.86% |
| 31 Mar, 21 | 132 | 4.76% | 54,621,973 | 43.76% | 89.59% | 1.32% | 74 | 37.04% | 35 | -30.00% |
| 31 Dec, 20 | 126 | -3.82% | 37,995,676 | 3.14% | 82.34% | 1.29% | 54 | -8.47% | 50 | 4.17% |
| 30 Sep, 20 | 131 | -2.96% | 36,839,372 | -2.44% | 79.75% | 1.19% | 59 | -26.25% | 48 | 29.73% |
| 30 Jun, 20 | 135 | 16.38% | 37,759,346 | 4.62% | 81.98% | 1.32% | 80 | 53.85% | 37 | -11.90% |
| 31 Mar, 20 | 116 | -3.33% | 36,090,579 | 0.25% | 78.93% | 1.27% | 52 | -24.64% | 42 | 23.53% |
| 31 Dec, 19 | 120 | 5.26% | 36,002,168 | 0.46% | 78.74% | 1.26% | 69 | 16.95% | 34 | 3.03% |
| 30 Sep, 19 | 114 | 4.59% | 35,838,126 | 0.54% | 78.91% | 1.28% | 59 | -6.35% | 33 | 13.79% |
| 30 Jun, 19 | 109 | -4.39% | 35,647,408 | -3.86% | 78.62% | 1.16% | 63 | 3.28% | 29 | -14.71% |
| 31 Mar, 19 | 114 | -0.87% | 37,077,308 | -1.94% | 82.17% | 1.17% | 61 | 19.61% | 34 | -20.93% |
| 31 Dec, 18 | 115 | -8.00% | 37,812,212 | 0.04% | 83.80% | 1.13% | 51 | -28.17% | 43 | 38.71% |
| 30 Sep, 18 | 125 | -14.97% | 37,795,442 | 16.65% | 86.06% | 1.24% | 71 | -20.22% | 31 | -27.91% |
| 30 Jun, 18 | 147 | 3.52% | 32,400,939 | 8.92% | 83.16% | 1.40% | 89 | 12.66% | 43 | -2.27% |
| 31 Mar, 18 | 142 | 18.33% | 29,746,208 | -1.33% | 76.97% | 1.17% | 79 | -2.47% | 44 | 83.33% |
| 31 Dec, 17 | 120 | 23.71% | 30,146,896 | 24.36% | 81.11% | 1.88% | 81 | 32.79% | 24 | 50.00% |
| 30 Sep, 17 | 97 | 7.78% | 24,242,513 | 9.67% | 65.61% | 1.82% | 61 | - | 16 | 14.29% |
| 30 Jun, 17 | 90 | 3.45% | 22,105,789 | 15.11% | 60.10% | 2.18% | 61 | 7.02% | 14 | -30.00% |
| 31 Mar, 17 | 87 | 27.94% | 19,204,334 | 13.92% | 52.56% | 2.43% | 57 | 50.00% | 20 | 53.85% |
| 31 Dec, 16 | 68 | 9.68% | 16,857,722 | -14.54% | 46.52% | 1.58% | 38 | 31.03% | 13 | - |
| 30 Sep, 16 | 62 | 3.33% | 19,725,253 | 4.67% | 54.30% | 1.99% | 29 | -36.96% | 13 | 116.67% |
| 30 Jun, 16 | 60 | 22.45% | 18,845,786 | 6.69% | 52.19% | 2.18% | 46 | 76.92% | 6 | -45.45% |
| 31 Mar, 16 | 49 | 2.08% | 17,663,927 | 1.79% | 48.98% | 2.12% | 26 | -45.83% | 11 | - |
| 31 Dec, 15 | 48 | - | 17,354,128 | - | 48.12% | - | 48 | - | - | - |
CytomX Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of CytomX Therapeutics's stock was made by McCarthy Sean A. on Mar 28 2024, selling 109,768 shares at $1.57 per share (valued at $172.87K).
CytomX Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 9 | - | - |
| Q1 2024 | 20 | 6 | 333.33% |
| Q4 2023 | 5 | 10 | 50.00% |
| Q3 2023 | 5 | 4 | 125.00% |
| Q2 2023 | 7 | 1 | 700.00% |
| Q1 2023 | 14 | 17 | 82.35% |
| Q3 2022 | 11 | 6 | 183.33% |
| Q2 2022 | 13 | 2 | 650.00% |
| Q1 2022 | 10 | 8 | 125.00% |
| Q4 2021 | 10 | - | - |
| Q3 2021 | 2 | 1 | 200.00% |
| Q2 2021 | 11 | 3 | 366.67% |
| Q1 2021 | 7 | 2 | 350.00% |
| Q4 2020 | 6 | 4 | 150.00% |
| Q3 2020 | 1 | 1 | 100.00% |
| Q2 2020 | 10 | 2 | 500.00% |
| Q1 2020 | 7 | - | - |
| Q4 2019 | 2 | - | - |
| Q3 2019 | - | 1 | - |
| Q2 2019 | 11 | 9 | 122.22% |
9 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by CytomX Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | 5 | - |
| Q4 2023 | - | 5 | - |
| Q3 2023 | - | 4 | - |
| Q2 2023 | - | - | - |
| Q1 2023 | 1 | 6 | 16.67% |
| Q3 2022 | - | 6 | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | 1 | - |
| Q1 2021 | - | 1 | - |
| Q4 2020 | - | - | - |
| Q3 2020 | - | - | - |
| Q2 2020 | - | 1 | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
| Q3 2019 | - | - | - |
| Q2 2019 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of CytomX Therapeutics's stocks.
CTMX Ownership FAQ
Who Owns CytomX Therapeutics?
CytomX Therapeutics is owned by institutional shareholders (10.26%), insiders (1.00%), and public (88.74%). The largest institutional shareholder of CytomX Therapeutics is TANG CAPITAL MANAGEMENT LLC (9.50% of total shares) and the top mutual fund owner is CORNERCAP GROUP OF FUNDS /VA/ (1.10% of total shares).
Who are the major institutional shareholders of CytomX Therapeutics?
CytomX Therapeutics's major institutional shareholders are TANG CAPITAL MANAGEMENT LLC, JANUS HENDERSON GROUP PLC, BVF INC/IL, VANGUARD GROUP INC, and ADAGE CAPITAL PARTNERS GP, L.L.C.. The top five shareholders own together 33.18% of the company's share outstanding.
How many CytomX Therapeutics shareholders are there?
As of Jun 2024, there are 24 institutional shareholders of CytomX Therapeutics.
What percentage of CytomX Therapeutics is owned by TANG CAPITAL MANAGEMENT LLC?
TANG CAPITAL MANAGEMENT LLC owns 7.79M shares of CytomX Therapeutics, representing 9.50% of the company's total shares outstanding, valued at $9.51M (as of Jun 2024).
What percentage of CytomX Therapeutics is owned by JANUS HENDERSON GROUP PLC?
As of Jun 2024, JANUS HENDERSON GROUP PLC holds 6.3M shares of CytomX Therapeutics (CTMX), compromising 7.68% of the company, valued at $7.72M.
What percentage of CytomX Therapeutics is owned by BVF INC/IL?
BVF INC/IL is the third largest holder of CytomX Therapeutics. The company owns 5.23M of the company's shares outstanding (worth $6.38M).